Extremely important positive changes in technical position have recently occurred for Neogenomics Inc (NASDAQ: NEO): stock’s 50 day m.a. turns up, and stock’s 200 day m.a. turns up.

Extremely important positive changes in technical position have recently occurred for Neogenomics Inc (NASDAQ: NEO): stock’s 50 day m.a. turns up, and stock’s 200 day m.a. turns up.

Extremely important positive changes in technical position have recently occurred for Neogenomics Inc (NASDAQ: NEO): stock’s 50 day m.a. turns up, and stock’s 200 day m.a. turns up.

Extremely important positive changes in technical position have recently occurred for Neogenomics Inc (NASDAQ: NEO): stock’s 50 day m.a. turns up, and stock’s 200 day m.a. turns up.

Current PriceTarget Research Rating

Neogenomics has a current Value Trend Rating of C (Low Neutral). This rating combines contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Neogenomics has a poor Appreciation Score of 26 but a slightly positive Power Rating of 65, producing the Low Neutral Value Trend Rating.

Recent Price Action

Extremely important positive changes in technical position have recently occurred for Neogenomics Inc (NASDAQ: NEO): stock’s 50 day m.a. turns up, and stock’s 200 day m.a. turns up.